FDA Adverse Event Injury Summary report: N

FLEXTEND II

MDR report key: 2173653 · Received July 23, 2011

Report

Report Number
2124215-2011-11057
Event Type
Injury
Date Received
July 23, 2011
Date of Event
June 10, 2011
Report Date
July 12, 2011
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THIS RA LEAD REMAINS IN SERVICE, SO THEREFORE WILL NOT BE RETURNED TO BOSTON SCIENTIFIC FOR LABORATORY ANALYSIS. AT THIS TIME THERE IS NO ADDITIONAL INFORMATION. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE THIS REPORT WILL BE UPDATED.

Additional Manufacturer Narrative · 1

RECEIVED ADDITIONAL INFORMATION THAT THIS RA LEAD WAS SURGICALLY ABANDONED. THERE IS NO INTENDED RETURN OF THIS PRODUCT. AT THIS TIME THERE IS NO ADDITIONAL INFORMATION. SHOULD ADDITIONAL INFORMATION BECOME AVAILABLE, THIS REPORT WILL BE UPDATED.

Description of Event or Problem · 1

BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS PATIENT, WHO HAS THIS RIGHT ATRIAL (RA) LEAD, DEVELOPED A FEVER, LEUKOCYTOSIS, AND A (B)(6). ANTIBIOTICS WERE GIVEN TO THE PATIENT TO TREAT THE (B)(6) INFECTION. THIS WAS SUSPECTED TO BE DUE TO PATIENT CONDITION, AND NOT RELATED TO DEVICE MALFUNCTION. THERE WERE NO ADDITIONAL ADVERSE PATIENT EFFECTS REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FLEXTEND II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4096

Patients

Seq Age Sex Outcome Treatment
1